Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Kim, J, Kim, S, Waters, P, Vincent, A, Park, K, Sung, J, Lee, K
Μορφή:	Conference item
Έκδοση:	2012

Παρόμοια τεκμήρια

Neuromyelitis optic with positive Anti-AQP4 and Anti-SSA/Ro antibody
ανά: Riwanti Estiasari, κ.ά.
Έκδοση: (2019-03-01)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
ανά: Yang, H, κ.ά.
Έκδοση: (2012)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
ανά: Kim, J, κ.ά.
Έκδοση: (2013)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
ανά: Kim, B, κ.ά.
Έκδοση: (2010)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
ανά: Martin S. Weber, κ.ά.
Έκδοση: (2018-03-01)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
ανά: Park, K, κ.ά.
Έκδοση: (2012)

Clinical spectrum of demyelinating disease of central nervous system and frequency of anti AQP4 and anti MOG among them: one-year single-center retrospective study
ανά: Heena Faldu, κ.ά.
Έκδοση: (2024-08-01)

Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
ανά: Kim, S, κ.ά.
Έκδοση: (2014)

Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
ανά: Akira Yoshida, κ.ά.
Έκδοση: (2023-12-01)

Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome
ανά: Koichi Yamaguchi, κ.ά.
Έκδοση: (2024-06-01)

Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating Disorders
ανά: Hye Lim Lee, κ.ά.
Έκδοση: (2021-07-01)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
ανά: Che Serguera, κ.ά.
Έκδοση: (2019-11-01)

Reversible Conduction Failure in Anti-lactosylceramide-antibody-positive Combined Central and Peripheral Demyelination
ανά: Masaya Harada, κ.ά.
Έκδοση: (2019-06-01)

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
ανά: Li Jiao, κ.ά.
Έκδοση: (2022-10-01)

Optic Nerve Demyelination in IgG4 Anti–Neurofascin 155 Antibody–Positive Combined Central and Peripheral Demyelination Syndrome
ανά: Alice Verghese, κ.ά.
Έκδοση: (2021-12-01)

Auto antibodies in inflammatory demyelinating diseases of the central nervous system
ανά: Swiss Medical Weekly
Έκδοση: (2008-11-01)

Sjögren’s syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody
ανά: Hideki Nakamura, κ.ά.
Έκδοση: (2024-11-01)

Anti-Ro Antibody and Its Significance
ανά: Chaicharoen Tantanate
Έκδοση: (2006-02-01)

Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats
ανά: Teruyuki Ishikura, κ.ά.
Έκδοση: (2021-08-01)

Clinical characteristics of anti-SRP antibody positive immune-mediated necrotizing myopathy with anti-TRIM21/Ro52 antibody positive
ανά: XU Li, GAO Huajie, YANG Mengge, LI Yue, JI Suqiong
Έκδοση: (2023-06-01)

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
ανά: Jun-ichi Kira, κ.ά.
Έκδοση: (2021-06-01)

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
ανά: Huang, Aric, κ.ά.
Έκδοση: (2022)

Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
ανά: Aric Huang, κ.ά.
Έκδοση: (2022-06-01)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
ανά: Elsone, L, κ.ά.
Έκδοση: (2014)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
ανά: Min, J, κ.ά.
Έκδοση: (2010)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
ανά: Sato, D, κ.ά.
Έκδοση: (2014)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
ανά: Waters, P, κ.ά.
Έκδοση: (2019)

Transverse Myelitis Associated with Anti-Ro (SSA) Autoantibodies: A Record of Two Cases
ανά: G. Melikyan, κ.ά.
Έκδοση: (2012-01-01)

Autoantibodies at the neuromuscular junction - Link to the central nervous system
ανά: Vincent, A
Έκδοση: (2014)

Psychiatric disorders in children with demyelinating diseases of the central nervous system
ανά: Pakpoor, J, κ.ά.
Έκδοση: (2017)

Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
ανά: Arkadiusz Koszarny, κ.ά.
Έκδοση: (2021-08-01)

Macrophages and Autoantibodies in Demyelinating Diseases
ανά: Haruki Koike, κ.ά.
Έκδοση: (2021-04-01)

Demyelinating Disease? Central Nervous System Lymphoma?
ανά: Ufuk Ergün, κ.ά.
Έκδοση: (2008-06-01)

Anti-Ro Positivity in Systemic Lupus Erythematosus: Association with Clinical Phenotypes and Other Antibodies
ανά: Anum Khan, κ.ά.
Έκδοση: (2024-01-01)

Anti-Ro and anti-La autoantibodies induce TNF-α production by human salivary gland cells: an in vitro study
ανά: V. Mitolo, κ.ά.
Έκδοση: (2011-09-01)

New autoantibody mediated disorders of the central nervous system.
ανά: Lang, B, κ.ά.
Έκδοση: (2003)

Olfactory Pathology in Central Nervous System Demyelinating Diseases.
ανά: DeLuca, G, κ.ά.
Έκδοση: (2014)

Peripheral nervous system involvement in MOG antibody-associated demyelination
ανά: Ramanathan, S, κ.ά.
Έκδοση: (2019)

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
ανά: P. Airò, κ.ά.
Έκδοση: (2011-09-01)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
ανά: Sotaro Mori, κ.ά.
Έκδοση: (2020-01-01)